Ivesco Holdings Llc
- View government funding actions
- Iowa Falls, IA 501269534
- Estimated Number of Employees: 370
- Estimated Annual Receipts: $420,953,879
Sampling of Federal Government Funding Actions/Set Asides
In order by amount of set aside monies.
- $8,357 - Wednesday the 14th of March 2012
Agricultural Research Service
USDA ARS PA 6538
IVERMAX - $6,875 - Monday the 24th of October 2011
Agricultural Research Service
USDA ARS PA 6538
LUTALYSE, FACTEROL, CIDRS - $6,840 - Tuesday the 21st of February 2012
Agricultural Research Service
USDA ARS PA 6538
GROWTH IMPLANTS - $39,773 - Friday the 10th of February 2012
Agricultural Research Service
USDA ARS PA 6538
LIVESTOCK VACCINES - $13,767 - Tuesday the 21st of August 2012
Office Of Procurement Operations
SCIENCE AND TECHNOLOGY ACQUISITION DIVISION
DIVISION/PPA: LABORATORY FACILITIES PROGRAM: LABORATORY OPERATIONS PROJECT: O&M PERFORMER: IVESCO APPROPRIATION YEAR: FY12 (26) BUDGET AUTHORITY: FIVE YEARS FUNDS PROJECT MANAGER: JIM HELT ALC: 70-08-1513 APPS: 70260800 DESCRIPTION: THE PURPOSE OF THIS REQUISITION IS TO PROVIDE FUNDS TO REPLENISH THE VIRKON INVENTORY AT PIADC. - $11,842 - Monday the 4th of June 2012
Agricultural Research Service
USDA ARS PA 6538
FACTERNAL, LUTALYSE, CIDRS, ESTRUS ALERT - $10,332 - Wednesday the 30th of May 2012
Office Of Procurement Operations
SCIENCE AND TECHNOLOGY ACQUISITION DIVISION
DIVISION: ONL PROGRAM: PIADC PROJECT: O&M PERFORMER: TBD APPROPRIATIONS YEAR: FY12 (26) BUDGET AUTHORITY: 5 YEAR FUNDS PROGRAM MANAGER: JIM HELT, (202) 254-6050 LEAD SUPPORT STAFF: MIKE CANESTARI ALC: 70-08-1513 APPS: 70260800 DESCRIPTION: THE PURPOSE OF THIS REQUEST IS TO FUND THE PURCHASE OF VIRKON-S DISINFECTANT IN THE AMOUNT OF $14,494.00. THIS PRODUCT IS USED IN BIOSECURITY OPERATIONS TO CONTROL THE SPREAD OF EXOTIC ANIMAL PATHOGENS IN PIADC BIOCONTAINMENT LABORATORY AND ANIMAL HOLDING AREAS INCLUDING HAVING A RESERVE FOR EMERGENCY OPERATIONS.
© Copyright 2019
The Collier Report published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources.
No reliance should be made by readers or Collier Report subscribers.
Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances.
Requests for the modification of displayed information may be made to help.desk@1918.media.